Insulet - 48 Year Dividend History | PODD

Historical dividend payout and yield for Insulet (PODD) since 1971. The current TTM dividend payout for Insulet (PODD) as of May 24, 2019 is $0.00. The current dividend yield for Insulet as of May 24, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $6.479B $0.564B
INSULET CORPORATION is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use components with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of continuous subcutaneous insulin infusion (CSII) therapy among people with insulin-dependent diabetes.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $135.807B 26.36
Medtronic (MDT) Ireland $124.767B 17.82
Stryker (SYK) United States $68.939B 24.60
Baxter (BAX) United States $38.314B 24.15
Zimmer Biomet Holdings (ZBH) United States $23.454B 15.07
Smith & Nephew SNATS (SNN) United Kingdom $18.518B 0.00
ResMed (RMD) United States $16.331B 31.20
Hill-Rom Holdings (HRC) United States $6.498B 19.70
Perrigo (PRGO) Ireland $6.439B 10.89
Phibro Animal Health (PAHC) United States $1.203B 18.02
LeMaitre Vascular (LMAT) United States $0.524B 25.35
Meridian Bioscience (VIVO) United States $0.477B 14.57
Utah Medical Products (UTMD) United States $0.302B 20.93
Owens & Minor (OMI) United States $0.219B 4.64
United-Guardian (UG) United States $0.091B 20.10